Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06041763 · ClinicalTrials.gov registry record · NA
Bridge-Enhanced ACL Repair (BEAR) in Meniscus Repair
A NA study of Meniscus Tear, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06041763 is a NA study of Meniscus Tear that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 80 participants, roughly in line with the 81-participant average among 6 other Meniscus Tear trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06041763, a NA study of Meniscus Tear, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The bridge-enhanced ACL repair (BEAR) implant is a collagen-based scaffold loaded with whole blood. It is designed to promote healing in the setting of intraarticular knee pathology. This study would compare clinical outcomes and synovial fluid cytokine profiles in patients who undergo isolated meniscal repair with or without the BEAR implant.
Conditions Studied
Interventions
- PROCEDURE Meniscal Repair Procedure
- DEVICE BEAR Implant
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-11-20 |
| Est. Completion | 2027-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06041763
The ClinicalTrials.gov registry entry for NCT06041763 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 81-participant average among 6 other Meniscus Tear trials with a reported enrollment target. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Meniscus Tear appearing as the primary indexed condition, and to 2 interventions - of which Meniscal Repair Procedure is the first listed.
NCT06041763 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06041763 about?
NCT06041763 is a clinical study titled "Bridge-Enhanced ACL Repair (BEAR) in Meniscus Repair". The bridge-enhanced ACL repair (BEAR) implant is a collagen-based scaffold loaded with whole blood. It is designed to promote healing in the setting of intraarticular knee pathology. This study would compare clinical outcomes and synovial fluid cytokine profiles in patients who undergo isolated meni...
What is the current status of trial NCT06041763?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-11-20. Estimated completion is 2027-11.
What conditions does trial NCT06041763 study?
This clinical trial studies the following conditions: Meniscus Tear.
What interventions are being tested in trial NCT06041763?
The interventions under investigation include: Meniscal Repair Procedure (PROCEDURE), BEAR Implant (DEVICE).
Who is sponsoring clinical trial NCT06041763?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06041763 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Meniscus Tear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Novel Bioactive Sleeve on Pain and PROMs
RECRUITING · NA
-
Outcomes of the Nanoscopic Partial Meniscectomy Versus Standard Arthroscopic Partial Meniscectomy
RECRUITING · NA
-
Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing
RECRUITING · Phase 1
-
Dronabinol After Arthroscopic Surgery
RECRUITING · Phase 3
-
MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)
RECRUITING · Early Phase 1
-
Corticosteroid Meniscectomy Randomized Trial
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.